| 臺大學術典藏 |
2021-07-03T03:34:38Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:34Z |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:33:19Z |
Ropeginterferon alfa-2b every 2?weeks as a novel pegylated interferon for patients with chronic hepatitis B
|
Huang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; Hsu S.-J.; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-06-01T07:03:11Z |
Hepatitis C virus infection: A risk factor for Parkinson's disease
|
Wu W.Y.-Y.; Kang K.-H.; Chen S.L.-S.; Chiu S.Y.-H.; Yen A.M.-F.; Fann J.C.-Y.; Su C.-W.; Liu H.-C.; Lee C.-Z.; WEN-MEI FU; Chen H.-H.; Liou H.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:49Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:24Z |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; CHEN-HUA LIU; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-05-05T03:31:09Z |
Energy-Efficient Monolithic 3-D SRAM Cell with BEOL MoS2FETs for SoC Scaling
|
Hu, V.P.-H.; Su, C.-W.; Lee, Y.-W.; Ho, T.-Y.; Cheng, C.-C.; Chen, T.-C.; Hung, T.Y.-T.; Li, J.-F.; Chen, Y.-G.; Li, L.-J.; VITA PI-HO HU |
| 臺大學術典藏 |
2021-02-03T03:56:17Z |
Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases
|
Su W.W.-Y.; Su C.-W.; Chang D.-C.; Chuang S.-L.; Chen S.L.-S.; Hsu C.-Y.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Lee Y.-H.; Jeng Y.-C.; Lee Y.-C.; HAN-MO CHIU; Chen T.H.-H.; Wang C.-P.; Chen M.-K. |
| 臺大學術典藏 |
2021-02-03T03:56:16Z |
Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer
|
Su W.W.-Y.; Chuang S.-L.; Yen A.M.-F.; Chen S.L.-S.; Fann J.C.-Y.; Chiu S.Y.-H.; HAN-MO CHIU; Su C.-W.; Hsu C.-Y.; Chen M.-K.; Chen H.-H.; Wang C.-P.; Lee Y.-C. |
| 臺大學術典藏 |
2021-02-02T07:50:56Z |
Hepatitis C virus infection: A risk factor for Parkinson's disease
|
Wu W.Y.-Y.; Kang K.-H.; Chen S.L.-S.; Chiu S.Y.-H.; Yen A.M.-F.; Fann J.C.-Y.; Su C.-W.; Liu H.-C.; Lee, Cha-Ze; Fu W.-M.; Chen H.-H.; Liou H.-H. |
| 臺大學術典藏 |
2021-02-02T05:45:06Z |
Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases
|
Su W.W.-Y.;Su C.-W.;Chang D.-C.;Chuang S.-L.;Chen S.L.-S.;Hsu C.-Y.;Yen A.M.-F.;Chiu S.Y.-H.;Fann J.C.-Y.;Lee Y.-H.;Jeng Y.-C.;Yi-Chia Lee;Chiu H.-M.;Chen T.H.-H.;Wang C.-P.;Chen M.-K.; Su W.W.-Y.; Su C.-W.; Chang D.-C.; Chuang S.-L.; Chen S.L.-S.; Hsu C.-Y.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Lee Y.-H.; Jeng Y.-C.; YI-CHIA LEE; Chiu H.-M.; Chen T.H.-H.; Wang C.-P.; Chen M.-K. |
| 臺大學術典藏 |
2021-02-02T05:45:05Z |
Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer
|
Su W.W.-Y.;Chuang S.-L.;Yen A.M.-F.;Chen S.L.-S.;Fann J.C.-Y.;Chiu S.Y.-H.;Chiu H.-M.;Su C.-W.;Hsu C.-Y.;Chen M.-K.;Chen H.-H.;Wang C.-P.;Yi-Chia Lee;; Su W.W.-Y.; Chuang S.-L.; Yen A.M.-F.; Chen S.L.-S.; Fann J.C.-Y.; Chiu S.Y.-H.; Chiu H.-M.; Su C.-W.; Hsu C.-Y.; Chen M.-K.; Chen H.-H.; Wang C.-P.; YI-CHIA LEE |
| 國立成功大學 |
2021 |
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
|
Teng, W.;Chang, T.-T.;Yang, H.-I.;Peng, C.-Y.;Su, C.-W.;Su, T.-H.;Hu, T.-H.;Yu, M.-L.;Yang, H.-C.;Wu, J.-C. |
| 臺大學術典藏 |
2020-12-28T08:14:10Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Yen-Hsuan Ni;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Wang P.-M.; Chao Y.; Chen L.-T.; Hsu C.; Cheng A.-L.; Lin C.-C.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-12-16T02:25:01Z |
Analysis of nondegraded and degraded DNA mixtures of close relatives using massively parallel sequencing
|
Hwa H.-L.; Wu M.-Y.; Lee J.C.-I.; Yin H.-I.; Hsu P.-M.; Li S.-F.; WUH-LIANG HWU; Su C.-W. |
| 臺大學術典藏 |
2020-11-03T15:39:21Z |
Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program
|
Yen A.M.-F.; Fann J.C.-Y; Chuang S.-L; CHENG-PING WANG; Chen M.-K; Su W.W.-Y; Su C.-W; Chen S.L.-S; Chiu S.Y.-H |
| 臺大學術典藏 |
2020-11-03T15:39:20Z |
Risk for a second primary hypopharyngeal and esophageal cancer after an initial primary oral cancer
|
Su W.W.-Y; Chuang S.-L; Yen A.M.-F; Chen S.L.-S; Fann J.C.-Y; Chiu S.Y.-H; Chiu H.-M; Su C.-W; Hsu C.-Y; Chen M.-K; Chen H.-H; CHENG-PING WANG; Lee Y.-C. |
| 臺大學術典藏 |
2020-11-03T15:39:20Z |
Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases
|
Su W.W.-Y; Su C.-W; Chang D.-C; Chuang S.-L; Chen S.L.-S; Hsu C.-Y; Yen A.M.-F; Chiu S.Y.-H; Fann J.C.-Y; Lee Y.-H; Jeng Y.-C; Lee Y.-C; Chiu H.-M; Chen T.H.-H; CHENG-PING WANG; Chen M.-K. |
| 臺大學術典藏 |
2020-08-11T08:36:42Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Po-Chin Liang;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Huo T.-I.; Liao L.-Y.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Lu S.-N. |
| 臺大學術典藏 |
2020-07-03T08:28:25Z |
A novel application of real-time RT-LAMP for body fluid identification: using HBB detection as the model
|
Su C.-W.;Li C.-Y.;James Chun-I Lee;Ji D.-D.;Li S.-Y.;Daniel B.;Syndercombe-Court D.;Linacre A.;Hsieh H.-M.; Su C.-W.; Daniel B.; Syndercombe-Court D.; Linacre A.; Hsieh H.-M.; Li S.-Y.; Ji D.-D.; Li C.-Y.; JAMES CHUN-I LEE |
| 臺大學術典藏 |
2020-07-03T08:28:22Z |
The detection and identification of saliva in forensic samples by RT-LAMP
|
Linacre A.; Hsieh H.-M.; Tsai L.-C.;Su C.-W.;James Chun-I Lee;Lu Y.-S.;Chen H.-C.;Lin Y.-C.;Linacre A.;Hsieh H.-M.; Tsai L.-C.; Su C.-W.; JAMES CHUN-I LEE; Lu Y.-S.; Chen H.-C.; Lin Y.-C. |
| 臺大學術典藏 |
2020-07-03T08:28:21Z |
Identification of spermatozoa using a novel 3-plex MSRE-PCR assay for forensic examination of sexual assaults
|
Liu K.-L.;Tsai L.-C.;Lin Y.-C.;Huang N.-E.;Yang L.-J.;Su C.-W.;James Chun-I Lee;Linacre A.;Hsieh H.-M.; Liu K.-L.; Tsai L.-C.; Lin Y.-C.; Huang N.-E.; Yang L.-J.; Su C.-W.; JAMES CHUN-I LEE; Linacre A.; Hsieh H.-M. |
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Huang Y.-H.; Lee K.-T.; Wang C.-C.; Chau G.-Y.; Lee W.-C.; Ting C.-T.; Lee P.-H.; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Chia-Hsien Cheng;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-02-26T07:30:10Z |
Hepatitis C virus infection: A risk factor for Parkinson's disease
|
Wu W.Y.-Y; Kang K.-H; Chen S.L.-S; Chiu S.Y.-H; Yen A.M.-F; Fann J.C.-Y; Su C.-W; Liu H.-C; Lee C.-Z; Fu W.-M; Chen H.-H; HORNG-HUEI LIOU |
| 臺大學術典藏 |
2020-02-19T09:33:41Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ming-Chih Ho;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group;Surveillance Group;Diagnosis Group;Staging Group;Surgery Group;Tace/Tare/Hai Group;Target Therapy/Systemic Therapy Group;Radiotherapy Group;Prevention Group;Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; MING-CHIH HO; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group |
